Tmunity is a clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T-cell immunotherapy to patients with devastating diseases.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
06/27/2022 | Series C | $72.24MM | $xx.xx | $129.44MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
86,510,314
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
10/31/2019 | Series B | $75MM | $xx.xx | $410.37MM | Andreessen Horowitz, Be The Match Biotherapies, Brightedge, Gilead Sciences, University Of Pennsylvania, Westlake Village Biopartners | |
Price per Share
$xx.xx
Shares Outstanding
7,718,744
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz, Be The Match Biotherapies, Brightedge, Gilead Sciences, University Of Pennsylvania, Westlake Village Biopartners
|
||||||
04/19/2018 | Series A | $136.6MM | $xx.xx | $309.54MM | Be The Match Biotherapies, Gilead Sciences, Kleiner Perkins, Lilly Asia Ventures, Parker Institute For Cancer Immunotherapy, Ping An Ventures, University Of Pennsylvania | |
Price per Share
$xx.xx
Shares Outstanding
14,793,171
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Be The Match Biotherapies, Gilead Sciences, Kleiner Perkins, Lilly Asia Ventures, Parker Institute For Cancer Immunotherapy, Ping An Ventures, University Of Pennsylvania
|
||||||
01/12/2016 | Series Seed | $8.68MM | $xx.xx | $43.39MM | Lilly Asia Ventures, University Of Pennsylvania | |
Price per Share
$xx.xx
Shares Outstanding
1,968,007
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Lilly Asia Ventures, University Of Pennsylvania
|